METHOD FOR DIAGNOSING THE CASES OF BONE METABOLISM DISORDER DISEASES Russian patent published in 2003 - IPC

Abstract RU 2203497 C2

FIELD: medicine. SUBSTANCE: method involves studying biological fluids for determining concentration of monomeric and homodimeric types of osteoclastogenesis-inhibiting factor (OCIF) in the biological fluid samples by means of monoclonal antibodies equally effective in recognizing both monomer and homodimeric types of OCIF and having dissociation constant less than 10-9 M with antigen or selectively recognizing dimeric OCIF type and having dissociation constant less than 2•10-7 M with antigen. A monoclonal antibody is claimed that is capable of equally effectively recognizing both monomer and homodimeric types of OCIF, as well as monoclonal antibody capable of selectively recognizing dimeric OCIF type and a set containing the above mentioned antibodies. EFFECT: high specificity and accuracy of measurements and diagnosis. 15 cl, 6 dwg, 1 tbl

Similar patents RU2203497C2

Title Year Author Number
COMPLEX COMPRISING OSTEOCLASTOGENESIS-INHIBITORY FACTOR (OCIF) AND POLYSACCHARIDE 2002
  • Jamamoto Siniti
  • Okada Dzuniti
  • Kurikhara Atsusi
  • Numazava Taku
  • Kondo Dzuniti
  • Tsuda Eisuke
  • Motizuki Siniti
  • Nisi Khirotaka
  • Mijazaki Khideki
RU2232594C2
ANTIBODY DIRECTED ON SIGLEC-15 PROTEIN, BOUND WITH OSTEOCLASTS 2008
  • Khiruma Josikharu
  • Tsuda Ejsuke
RU2475499C2
NOVEL PROTEINS AND METHODS OF THEIR PREPARING 1996
  • Goto Masaaki
  • Tsuda Ehjsuke
  • Motizuki Siniti
  • Jano Kazuki
  • Kobajasi Fumie
  • Sima Nobujuki
  • Jasuda Khisataka
  • Nakagava Nobuaki
  • Morinaga Tomonori
  • Ueda Masatsugu
  • Khigasio Kandzi
RU2194714C2
PROTEIN ABLE TO INHIBIT OSTEOCLASTOGENESIS (OCIF) (VARIANTS), CDNA, METHOD FOR PREPARING PROTEIN, METHOD FOR TREATMENT OF OSTEOPOROSIS, METHOD FOR TREATMENT AND/OR IMPROVEMENT OF BONE MASS RECOVERY, METHOD FOR TREATMENT OF INJURE ASSOCIATED WITH OSSEOUS METABOLISM, TRANSFORMED STRAIN ESCHERICHIA COLI PBK/01F10 AND PHARMACEUTICAL COMPOSITION 1996
  • Goto Masaaki
  • Tsuda Ehjsuke
  • Motizuki Siniti
  • Jano Kazuki
  • Kobajasi Fumie
  • Sima Nobujuki
  • Jasuda Khisataka
  • Nakagava Nobuaki
  • Morinaga Tomonori
  • Ueda Masatsugu
  • Khigasio Kandzi
RU2238948C2
Siglec-15 ANTIBODY 2010
  • Khiruma Josikharu
  • Tsuda Ejsuke
  • Takizava Takesi
  • Nakajama Makiko
RU2539790C2
PROTEIN BINDING SPECIFICALLY WITH OSTEOCLASTOGENESIS-INHIBITING FACTOR (OCIF) (VARIANTS), DNA ENCODING ITS (VARIANTS), DNA AS PROBE (VARIANTS), METHOD FOR PREPARING PROTEIN (VARIANTS), METHOD FOR SCREENING SUBSTANCE (VARIANTS), ANTIBODY (VARIANTS), METHOD FOR PREPARING POLYCLONAL ANTIBODY, HYBRIDOMA (VARIANTS), METHOD FOR PREPARING MONOCLONAL ANTIBODY, METHOD FOR ASSAY OF OCIF-BINDING PROTEIN, PHARMACEUTICAL COMPOSITION (VARIANTS) AND MEDICINAL AGENT (VARIANTS) 1998
  • Jamaguti Kiodzi
  • Jasuda Khisataka
  • Nakagava Nobuaki
  • Sima Nobujuki
  • Kinosaki Masakhiko
  • Tsuda Eisuke
  • Goto Masaaki
  • Jano Kazuki
  • Tomojasu Akikhiro
  • Kobajasi Fumie
  • Vasida Naokhiro
  • Takakhasi Ken
  • Morinaga Tomonori
  • Khigasio Kandzi
RU2238949C2
POLYNUCLEOTIDE SEQUENCE (VARIANTS), POLYPEPTIDE (VARIANTS), FUSED PROTEIN, PHARMACEUTICAL COMPOSITION, MONOCLONAL ANTIBODY, STRAIN OF HYBRID CULTURED CELLS 1995
  • Tokhru Takakhasi
  • Rjuta Koisi
  • Itiro Kavasima
  • Nobufuza Serizava
RU2143491C1
ANTIBODY AGAINST TUMOR-SPECIFIC ANTIGENS AS TARGET 2004
  • Itikava Kimikhisa
  • Takakhasi Su
  • Agatsuma Tosinori
  • Fukuti Kejsuke
  • Khirai Takekhiro
RU2345090C2
POLYMERIC MODIFYING AGENTS AND PHARMACEUTICAL COMPOSITIONS 2004
  • Kasuja Judzi
  • Khonma Masasi
RU2323227C2
ANTI-ROBO4 ANTIBODY 2013
  • Isumi Joshitaka
  • Sato Toshiyuki
  • Khasegava Dzhun
  • Inoue Tatsuya
RU2682451C2

RU 2 203 497 C2

Authors

Jano Kazuki

Kobajasi Fumie

Goto Masaaki

Vasida Naokhiro

Tsuda Ehjsuke

Khigasio Kandzi

Jamada Josidzi

Dates

2003-04-27Published

1998-07-31Filed